Published in Biotech Business Week, August 23rd, 2004
Under the terms of the funding agreements with Cornell Capital Partners, LP, a New Jersey-based domestic investment fund, Provectus has obtained $750,000 in Convertible Securities and a firm commitment of $20 million under a Standby Equity Distribution Agreement. Provectus may, at its discretion, issue shares to Cornell at any time over the next 2 years.
The maximum aggregate amount of the equity placements pursuant to the agreement is $20 million. Subject to this limitation, Provectus may...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.